Author

T. Hillenaar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

I. Braakman· 2 shared P. van der Sluijs· 2 shared H. Y. Yeoh· 1 shared J. Beekman· 1 shared J. Im· 1 shared M. Mijnders· 1 shared M. van Willigen· 1 shared P. Sahasrabudhe· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

I. Braakman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Redefining hypo- and hyper-responding phenotypes of CFTR mutants for understanding and therapy.

T. Hillenaar, J. Beekman, P. van der Sluijs, I. Braakman

The paper identifies biochemical and functional characteristics of CFTR mutants that respond poorly or exceptionally well to modulators, informing improved therapeutic strategies.

bioRxiv · Sep 12, 2022Biochemistry

ABC-transporter CFTR folds with high fidelity through a modular, stepwise pathway

J. Im, T. Hillenaar, H. Y. Yeoh, P. Sahasrabudhe, M. Mijnders, M. van Willigen, P. van der Sluijs, I. Braakman

This study reveals the stepwise folding pathway of CFTR, showing two distinct stages of domain folding and assembly, with implications for understanding protein misfolding diseases.

bioRxiv · Jul 20, 2022Biochemistry